Objective: To investigate the clinical efficacy of the Danxiang Guanxin injection combined with Xingling dispersible tablet for treating angina pectoris with heart stagnation. Method: One hundred and twenty-eight patients with angina pectoris were admitted in hospital from June 2009 to June 2012

they were randomly divided into control group and observation group (n=64 each). The control group was given Danxiang Guanxin injection for treatment while the observation group was received Xingling dispersible tablet on the basis of the control group. After 6 weeks

the clinical efficacy was compared between the two groups. Result: The clinical efficacy of the observation group was significantly better than that of the control group (P<0.05

P<0.01); after the treatment

the serum lipids levels and hemorheological parameters of the observation group were significantly better than those of the control group (P<0.01). Nitroglycerin discontinuation rate in the observation group was higher than that in the control group (P<0.05); and the adverse reactions between the two groups showed no significant difference. Conclusion: Danxiang Guanxin injection combined with Xingling dispersible tablet can effectively improve the hemorheological parameters and serum lipids levels for the patients suffered from angina pectoris with heart stagnation. The clinical effect is significant

and has less adverse reactions

which is worth to be applied in clinic.